Telehealth GLP-1 vs In-Person: Pros, Cons, and What to Know Before Choosing

The decision that did not exist five years ago

Before 2020, if you wanted GLP-1 medication for weight loss, you had one path: find a local provider, schedule an in-person appointment, wait in a waiting room, and hope your insurance covered it. Today, telemedicine platforms offer a completely different model — online intake, asynchronous provider review, and medication shipped to your door. Both paths can lead to effective treatment. They differ in cost, convenience, speed, and the type of ongoing relationship you have with your provider. If you are deciding between telehealth platforms, our provider selection checklist covers what to verify on safety, cost, and transparency before you pay. Already on treatment and thinking about a change? See our guide to switching GLP-1 providers.

Cost comparison: the biggest practical difference

For most people, cost is the deciding factor. Here is how the two paths compare on price:

• In-person visit costs: Specialist copays typically range from $40-$80 with insurance, or $150-$400 without. Primary care visits are lower but many PCPs are not comfortable prescribing GLP-1 medications for weight loss and may refer you to a specialist — adding another visit cost.
• In-person medication costs: If prescribed a brand-name GLP-1 like Wegovy or Zepbound through an in-person provider, you are at the mercy of your insurance formulary. Without coverage, list prices exceed $1,000 per month. With coverage, prior authorization and step therapy requirements are common.
• Telehealth costs: Most telehealth platforms bundle the provider review into the program price. Surfbound includes the provider review at no separate charge. Compounded medication pricing through telehealth typically runs $169-$399 per month — 60-80% below brand-name list prices.
• Total cost comparison: For someone without GLP-1 insurance coverage, telehealth with compounded medication typically costs $200-$400 per month all-in. In-person with brand-name medication without coverage can exceed $1,200 per month. For someone with excellent insurance, in-person may be cheaper — but availability of coverage for weight loss medications remains inconsistent.

Convenience and speed

Telehealth wins decisively on convenience, but in-person has advantages for certain situations:

• Scheduling: Telehealth intake is available 24/7 — complete it on your schedule, not the clinic's. In-person requires finding an available appointment, which for weight loss specialists can mean weeks of waiting.
• Travel and time: Telehealth eliminates commuting, parking, waiting rooms, and the 90+ minute block that an in-person visit typically consumes.
• Geographic access: If you live in a rural area or a region with few weight loss specialists, telehealth eliminates geography as a barrier. You have access to providers licensed in your state regardless of where they are physically located.
• Speed to treatment: Telehealth platforms typically complete provider review within 24-48 hours. In-person pathways often involve multiple visits — initial consultation, lab work, follow-up to review results, then prescription. This can take weeks.

Quality of care: the nuance people miss

The reflexive assumption is that in-person care is higher quality. The reality is more nuanced:

• Provider qualifications: Both telehealth platforms and in-person clinics use licensed providers — MDs, DOs, NPs, and PAs. The license is the same. The difference is in how they practice, not whether they are qualified.
• Personal relationship: An in-person provider who you see regularly may develop a deeper understanding of your health over time. This is the strongest argument for in-person care — continuity of relationship.
• Physical examination: In-person visits allow for hands-on physical examination, which may catch things a telehealth intake cannot. However, for GLP-1 prescribing specifically, the relevant clinical data (weight, BMI, blood pressure, lab values) does not necessarily require hands-on examination.
• Lab work: In-person providers can draw labs in-office. Telehealth providers may order labs that you complete at a local facility. The labs are the same — the logistics differ.
• Attention and thoroughness: A rushed in-person provider working through a packed schedule may spend less time reviewing your case than a telehealth provider reviewing your intake asynchronously with fewer time constraints.

Medication access: compounded vs brand-name

This is where the paths diverge most dramatically. In-person providers typically prescribe brand-name GLP-1 medications (Wegovy, Zepbound, Ozempic, Mounjaro). These are FDA-approved products with extensive clinical trial data. But they are expensive and may not always be accessible.

Telehealth platforms often offer compounded GLP-1 medications as an alternative. Compounded medications are not FDA-approved — they are prepared by licensed compounding pharmacies and are not reviewed by the FDA for safety, effectiveness, or quality before marketing. However, they are typically far more affordable. Compounded medications may be prescribed for an individual patient when clinically appropriate and permitted under applicable federal and state law.

The trade-off is real: FDA-approved certainty at a higher price versus compounded accessibility at a lower price with different regulatory oversight. A licensed provider can help you understand which option is appropriate for your situation.

Ongoing support and follow-up

After the initial prescription, your ongoing experience differs between the two paths:

• Telehealth: Follow-up is typically asynchronous — messages through a patient portal, periodic check-in forms, and the ability to message your provider with questions. Some platforms offer video visits. The frequency of follow-up varies by platform.
• In-person: Follow-up visits are scheduled at intervals (often every 1-3 months). Each visit involves travel, waiting, and a copay or visit fee. The face-to-face time may be brief — 15-20 minutes is typical.
• Emergency access: Neither telehealth nor routine in-person care is appropriate for medical emergencies. For urgent concerns, both paths require you to seek emergency or urgent care separately.

Who should choose telehealth

Telehealth GLP-1 treatment tends to work well for people who:

• Are generally healthy aside from excess weight — no complex, unstable medical conditions requiring frequent hands-on monitoring
• Value convenience and want to avoid the time burden of in-person appointments
• Do not have insurance coverage for GLP-1 medications and are looking for more affordable compounded options
• Are comfortable with digital communication and do not need face-to-face interaction to feel confident in their care
• Live in areas with limited access to weight loss specialists

Who should choose in-person

In-person GLP-1 treatment may be a better fit for people who:

• Have complex medical histories with multiple conditions requiring coordinated, hands-on management
• Have excellent insurance coverage for weight loss medications and can access brand-name GLP-1s affordably
• Strongly prefer face-to-face relationships with their healthcare providers
• Need or want regular physical examination as part of their ongoing care
• Are not comfortable with digital health platforms or asynchronous communication

The hybrid approach

It does not have to be all or nothing. Some people start with telehealth to get treatment quickly and affordably, then transition to an in-person provider for long-term maintenance. Others use telehealth for the GLP-1 prescription while maintaining an in-person relationship with a primary care provider for other health needs. The best approach is the one that gets you consistent, sustainable treatment that fits your life and budget.